Baird downgraded NewLink Genetics (NASDAQ: NLNK) from Outperform to Neutral with a price target of $8.00 (from $25.00) following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE